Arthrys is a new medical device based on low molecular weight collagen peptides (LWPs). It is a ready-to-use injectable solution for the intra-articular treatment of osteoarthritis and structural strengthening of connective tissues.
ARTHRYS® LWPs (approx. 3 kDa) derive from the hydrolytic fragmentation of collagen, which undergoes purification and filtration. The Arthrys injection solution allows the LWPs to spread in the joint environment, acting as a direct reinforcement of the extracellular matrix of connective tissues deteriorated by degenerative, inﬂammatory, or traumatic events.